Advertisement

Comparison of femoropopliteal plain balloon angioplasty for chronic limb-threatening ischemia in the BASIL trial and in a UK contemporary series

      Abstract

      Background

      Since the turn of the millennium, there has been a worldwide trend towards an endovascular-first strategy where possible revascularization strategy for chronic limb-threatening ischemia. There is concern that this may be inappropriate and can result in net patient harm. The aim of this study, therefore, is to compare important clinical outcomes following femoropopliteal plain balloon angioplasty (FP-PBA), with selective use of bare metal stents (BMSs), in a contemporary series (CS) of patients treated in our unit between 2009 and 2014 with those observed following FP-PBA ± BMS in the United Kingdom National Institute of Health Research Health Technology Assessment-funded Bypass vs Angioplasty in Severe Ischaemia of the Leg (BASIL-1 [B1]) trial (treated 1999-2004).

      Methods

      Baseline and clinical outcome data (amputation-free survival [AFS], overall survival [OS], limb salvage, freedom from reintervention, and freedom from major adverse limb events) were obtained from prospectively gathered hospital data and B1 trial case record forms.

      Results

      There were 237 CS and 218 B1 patients. CS patients were older (77 vs 73 years; P = .0002). B1 patients were more likely to be current smokers, less likely to be on best medical therapy, and underwent more extensive endovascular interventions. CS had more hospital admissions (4 vs 2; P < .0001) before they reached their primary endpoint (AFS). Immediate technical success was nonsignificantly higher in the CS patients (87% vs 83%; P = .2). BMS were used in 20 CS (8%) and 2 B1 (1%) patients (P = .0002). AFS (hazard ratio, 0.64; 95% confidence interval, 0.49-0.82; P = .0005) and OS (hazard ratio, 0.58; 95% confidence interval, 0.44-0.76; P = .0001) were significantly worse in the CS cohort. There was no significant difference in limb salvage, freedom from reintervention, or freedom from major adverse limb events.

      Conclusions

      Patients with chronic limb-threatening ischemia managed in our unit (2009-2014) by means of a FP-PBA ± BMS first (where possible) revascularization strategy experienced significantly worse AFS and OS than patients treated with FP-PBA ± BMS in the B1 trial 10 years earlier (1999-2004).

      Keywords

      To read this article in full you will need to make a payment
      SVS Member Login
      Society Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Fowkes F.G.R.
        • Rudan D.
        • Rudan I.
        • Aboyans V.
        • Denenberg J.O.
        • McDermott M.M.
        • et al.
        Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis.
        Lancet. 2013; 382: 1329-1340
        • Norgren L.
        • Hiatt W.R.
        • Dormandy J.A.
        • Nehler M.R.
        • Harris K.A.
        • Fowkes F.G.R.
        • et al.
        • TASC II Working Group
        Inter-society consensus for the management of peripheral arterial disease (TASC II).
        J Vasc Surg. 2007; 33: S1-S75
        • Goodney P.P.
        • Beck A.W.
        • Nagle J.
        • Welch H.G.
        • Zwolak R.M.
        National trends in lower extremity bypass surgery, endovascular interventions, and major amputations.
        J Vasc Surg. 2009; 50: 54-60
        • Bradbury A.W.
        • Adam D.J.
        • Bell J.
        • Forbes J.F.
        • Fowkes G.R.
        • Gillespie I.
        • et al.
        • BASIL trial Participants
        Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy.
        J Vasc Surg. 2010; 51: 5S-17S
        • Darling J.D.
        • McCallum J.C.
        • Soden P.A.
        • Korepta L.
        • Guzman R.J.
        • Wyers M.C.
        • et al.
        Results for primary bypass versus primary angioplasty/stent for lower extremity chronic limb-threatening ischemia.
        J Vasc Surg. 2017; 66: 466-475
        • Robinson W.P.
        • Loretz L.
        • Hanesian C.
        • Flahive J.
        • Bostrom J.
        • Lunig N.
        • et al.
        Society for Vascular Surgery Wound, Ischemia, foot Infection (WIfI) score correlates with the intensity of multimodal limb treatment and patient-centered outcomes in patients with threatened limbs managed in a limb preservation center.
        J Vasc Surg. 2017; 66: 488-498.e2
        • Sigvant B.
        • Hasvold P.
        • Kragsterman B.
        • Falkenberg M.
        • Johansson S.
        • Thuresson M.
        • et al.
        Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: results from a Swedish nationwide study.
        J Vasc Surg. 2017; 66: 507-514
        • Jongsma H.
        • Akkersdijk G.P.
        • de Smet A.A.E.A.
        • Vroegindeweij D.
        • de Vries J.P.M.
        • Fioole B.
        Drug-eluting balloons and uncoated balloons perform equally to rescue infrainguinal autologous bypasses at risk.
        J Vasc Surg. 2017; 66: 454-460
        • Mehaffey J.H.
        • Hawkins R.B.
        • Fashandi A.
        • Cherry K.J.
        • Kern J.A.
        • Kron I.L.
        • et al.
        Lower extremity bypass for critical limb ischemia decreases major adverse limb events with equivalent cardiac risk compared with endovascular intervention.
        J Vasc Surg. 2017; 66: 1109-1116.e1
        • Abu Dabrh A.M.
        • Steffen M.W.
        • Asi N.
        • Undavalli C.
        • Wang Z.
        • Elamin M.
        • et al.
        Bypass surgery versus endovascular interventions in severe or critical limb ischemia.
        J Vasc Surg. 2016; 63: 244-253.E11
        • Kudo T.
        • Chandra F.A.
        • Kwun W.H.
        • Haas B.T.
        • Ahn S.S.
        Changing pattern of surgical revascularization for critical limb ischaemia over 12 years: endovascular vs. open bypass surgery.
        J Vasc Surg. 2006; 44: 304-313
        • Bollinger A.
        • Breddin K.
        • Hess H.
        • Heystraten F.M.
        • Kollath J.
        • Konttila A.
        • et al.
        Semiquantitative assessment of lower limb atherosclerosis from routine angiographic images.
        Atherosclerosis. 1981; 38: 339-346
        • Conte M.S.
        • Bradbury A.W.
        • Kolh P.
        • White J.V.
        • Dick F.
        • Fitridge R.
        • et al.
        • GVG Writing Group for the Joint Guidelines of the Society for Vascular Surgery (SVS), European Society for Vascular Surgery (ESVS), and World Federation of Vascular Societies (WFVS)
        Global Vascular Guidelines on the management of chronic limb-threatening ischaemia.
        Eur J Vasc Endovasc Surg. 2019; 58: S1-S109.e33
        • Goy J.J.
        • Urban P.
        Life and limb: bypass versus angioplasty in the ischaemic limb.
        Lancet. 2005; 366: 1905-1906
        • Cull D.L.
        • Langan E.M.
        • Gray B.H.
        • Johnson B.
        • Taylor S.M.
        Open versus endovascular intervention for critical limb ischaemia: a population based study.
        J Am Coll Surg. 2010; 210 (561-3): 555-561
        • Jahnke T.
        • Voshage G.
        • Müller-Hülsbeck S.
        • Grimm J.
        • Heller M.
        • Brossmann J.
        Endovascular placement of self-expanding nitinol coil stents for the treatment of femoropopliteal obstructive disease.
        J Vasc Interv Radiol. 2002; 13: 257-266
        • Chang Z.
        • Zheng J.
        • Liu Z.
        Subintimal angioplasty for lower limb arterial chronic total occlusions.
        Cochrane Database Syst Rev. 2016; 11: CD009418
        • Schillinger M.
        • Sabeti S.
        • Loewe C.
        • Dick P.
        Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery.
        N Engl J Med. 2006; 354: 1879-1888
        • Yang X.
        • Lu X.
        • Ye K.
        • Li X.
        • Qin J.
        • Jiang M.
        Systematic review and meta-analysis of balloon angioplasty versus primary stenting in the infrapopliteal disease.
        Vasc Endovascular Surg. 2014; 48: 18-26
        • Schulte K.L.
        • Pilger E.
        • Schellong S.
        • Tan K.T.
        • Bauman F.
        • Langhoff R.
        • et al.
        • EXPAND Investigators
        Primary self-EXPANDing nitinol stenting vs balloon angioplasty with optional bailout stenting for the treatment of infrapopliteal artery disease in patients with severe intermittent claudication or critical limb ischemia (EXPAND Study).
        J Endovasc Ther. 2015; 22: 690-697
        • National Institute of Clinical Excellence
        Peripheral arterial disease: diagnosis and management clinical guideline. (CG147). 21 Feb 2018.
        (Available at:)
        https://www.nice.org.uk/guidance/cg147
        Date accessed: August 12, 2021
        • Meecham L.
        • Popplewell M.
        • Bate G.
        • Patel S.
        • Bradbury A.W.
        Contemporary (2009-2014) clinical outcomes after femoropopliteal bypass surgery for chronic limb threatening ischemia are inferior to those reported in the UK Bypass versus Angioplasty for Severe Ischaemia of the Leg (BASIL) trial (1999-2004).
        J Vasc Surg. 2019; 69: 1840-1847
        • Popplewell M.A.
        • Davies H.O.B.
        • Renton M.
        • Bate G.
        • Deeks J.J.
        • Bradbury A.W.
        Comparison of outcomes following infrapopliteal plain balloon angioplasty in the BASIL trial (1999-2004) and in a contemporary series (2009-2013).
        Vasc Endovasc Surg. 2020; 54: 141-146
        • Katsanos K.
        • Spiliopoulos S.
        • Kitrou P.
        • Krokidis M.
        • Karnabatidis D.
        Risk of death following application of paclitaxel-oated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials.
        J Am Heart Assoc. 2018; 7: e011245
        • Popplewell M.A.
        • Davies H.
        • Jarrett H.
        • Bate G.
        • Grant M.
        • Patel S.
        • et al.
        • BASIL-2 Trial Investigators
        Bypass versus angio plasty in severe ischaemia of the leg-2 (BASIL-2) trial: study protocol for a randomised controlled trial.
        Trials. 2016; 17: 11
        • Hunt B.D.
        • Popplewell M.A.
        • Davies H.
        • Meecham L.
        • Jarrett H.
        • Bate G.
        • et al.
        • BASIL-3 Collaborative Group
        BAlloon versus Stenting in severe Ischaemia of the Leg-3 (BASIL-3): study protocol for a randomised controlled trial.
        Trials. 2017; 18: 224
        • Menard M.T.
        • Farber A.
        • Assmann S.F.
        • Choudhry N.K.
        • Conte M.S.
        • Creager M.A.
        • et al.
        Design and Rationale of the Best Endovascular versus Best Surgical Therapy for patients with Critical Limb Ischemia (BEST-CLI) Trial.
        J Am Heart Assoc. 2016; 5: e003219